These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 6304508)

  • 21. Immunopathology of myasthenia gravis.
    Drachman DB
    Fed Proc; 1979 Nov; 38(12):2613-5. PubMed ID: 227751
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of humoral immunity in myasthenia gravis.
    Zurn AD; Fulpius BW
    Prog Brain Res; 1979; 49():435-40. PubMed ID: 229518
    [No Abstract]   [Full Text] [Related]  

  • 23. Acetylcholine concentration into voltage. Receptor-mediated transduction.
    Stevens CF
    Soc Gen Physiol Ser; 1979; 33():79-89. PubMed ID: 218311
    [No Abstract]   [Full Text] [Related]  

  • 24. Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity.
    Mossman S; Vincent A; Newsom-Davis J
    Lancet; 1986 Jan; 1(8473):116-9. PubMed ID: 2417076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immunopathology of myasthenia gravis.
    Engel AG
    Int J Neurol; 1980; 14(1):35-46. PubMed ID: 6293990
    [No Abstract]   [Full Text] [Related]  

  • 26. A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro.
    Burges J; Wray DW; Pizzighella S; Hall Z; Vincent A
    Muscle Nerve; 1990 May; 13(5):407-13. PubMed ID: 2345558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic experimental autoimmune myasthenia gravis induced by monoclonal antibody to acetylcholine receptor: biochemical and electrophysiologic criteria.
    Gomez CM; Richman DP
    J Immunol; 1987 Jul; 139(1):73-6. PubMed ID: 3035025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acetylcholine release in diaphragm of rats with chronic experimental autoimmune myasthenia gravis.
    Kelly JJ; Lambert EH; Lennon VA
    Ann Neurol; 1978 Jul; 4(1):67-72. PubMed ID: 211931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte responsiveness to acetylcholine receptor in rats with experimental autoimmune myasthenia gravis.
    Noguchi SA; Drachman DB; Adams RN; Hirsch RL
    Ann Neurol; 1980 Jul; 8(1):32-7. PubMed ID: 7406445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental autoimmune myasthenia gravis.
    Lindstrom J
    J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):568-76. PubMed ID: 6249892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myasthenia gravis: passive transfer to mice of antibody to human and mouse acetylcholine receptor.
    Oda K; Korenaga S; Ito Y
    Neurology; 1981 Mar; 31(3):282-7. PubMed ID: 6259556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors.
    Lennon VA; Lambert EH
    Nature; 1980 May; 285(5762):238-40. PubMed ID: 6154894
    [No Abstract]   [Full Text] [Related]  

  • 35. Myasthenia gravis (first of two parts).
    Drachman DB
    N Engl J Med; 1978 Jan; 298(3):136-42. PubMed ID: 201840
    [No Abstract]   [Full Text] [Related]  

  • 36. [Myasthenia gravis in newborn infants--pathological mechanism, clinical symptomatology and therapeutic procedures].
    Krauze M; Musialik E; Swietliński J; Litwa K; Latko E; Górny J; Sobczyk J
    Wiad Lek; 1992 Aug; 45(15-16):610-4. PubMed ID: 1488831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Passive transfer of myasthenia gravis by immunoglobulins: lack of correlation between AChR with antibody bound, acetylcholine receptor loss and transmission defect.
    Mossman S; Vincent A; Newsom-Davis J
    J Neurol Sci; 1988 Mar; 84(1):15-28. PubMed ID: 2835437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgG.
    Toyka KV; Löwenadler B; Heininger K; Besinger UA; Birnberger KL; Fateh-Moghadam A; Heilbronn E
    J Neurol Neurosurg Psychiatry; 1980 Sep; 43(9):836-42. PubMed ID: 6252294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
    Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC
    Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A postnatal change in the immunological properties of the acetylcholine receptor at rat muscle endplates.
    Hall ZW; Gorin PD; Silberstein L; Bennett C
    J Neurosci; 1985 Mar; 5(3):730-4. PubMed ID: 3973693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.